Clinuvel Pharmaceuticals Ltd (CLVLY)
10.00
+0.04
(+0.45%)
USD |
OTCM |
Sep 23, 16:00
Clinuvel Pharmaceuticals Price: 10.00 for Sept. 23, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Sep 23, 2024 | 10.00 | 10.00 | 10.00 | 10.00 | 110.00 |
Sep 20, 2024 | 9.955 | 9.955 | 9.955 | 9.955 | 0.000 |
Sep 19, 2024 | 9.955 | 9.955 | 9.955 | 9.955 | 899.00 |
Sep 18, 2024 | 9.785 | 9.785 | 9.785 | 9.785 | 136.00 |
Sep 17, 2024 | 10.12 | 10.12 | 10.12 | 10.12 | 271.00 |
Sep 16, 2024 | 10.00 | 10.00 | 10.00 | 10.00 | 0.000 |
Sep 13, 2024 | 10.00 | 10.00 | 10.00 | 10.00 | 500.00 |
Sep 12, 2024 | 9.90 | 9.90 | 9.90 | 9.90 | 304.00 |
Sep 11, 2024 | 9.85 | 9.85 | 9.85 | 9.85 | 1338.00 |
Sep 10, 2024 | 9.60 | 9.65 | 9.60 | 9.65 | 5777.00 |
Sep 09, 2024 | 9.43 | 9.75 | 9.43 | 9.75 | 817.00 |
Sep 06, 2024 | 9.425 | 9.425 | 9.425 | 9.425 | 0.000 |
Sep 05, 2024 | 8.69 | 9.425 | 8.69 | 9.425 | 661.00 |
Sep 04, 2024 | 10.03 | 10.03 | 10.03 | 10.03 | 0.000 |
Sep 03, 2024 | 10.70 | 10.70 | 10.03 | 10.03 | 3331.00 |
Aug 30, 2024 | 10.44 | 10.44 | 10.30 | 10.30 | 4286.00 |
Aug 29, 2024 | 10.33 | 10.33 | 10.33 | 10.33 | 4374.00 |
Aug 28, 2024 | 9.405 | 9.434 | 9.405 | 9.434 | 429.00 |
Aug 27, 2024 | 9.20 | 9.24 | 9.20 | 9.24 | 4988.00 |
Aug 26, 2024 | 9.25 | 9.25 | 9.25 | 9.25 | 0.000 |
Aug 23, 2024 | 8.90 | 9.25 | 8.90 | 9.25 | 1105.00 |
Aug 22, 2024 | 9.01 | 9.01 | 8.94 | 8.94 | 1058.00 |
Aug 21, 2024 | 9.06 | 9.06 | 9.06 | 9.06 | 511.00 |
Aug 20, 2024 | 9.16 | 9.16 | 9.16 | 9.16 | 102.00 |
Aug 19, 2024 | 8.82 | 9.20 | 8.82 | 8.87 | 5760.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
8.10
Minimum
Mar 18 2020
31.29
Maximum
Sep 23 2021
15.27
Average
14.33
Median
Price Benchmarks
Alterity Therapeutics Ltd | 1.22 |
Kazia Therapeutics Ltd | 0.3232 |
Immutep Ltd | 2.29 |
Opthea Ltd | 3.99 |
Mesoblast Ltd | 7.16 |
Price Related Metrics
PE Ratio | 21.81 |
PS Ratio | 8.822 |
PEG Ratio | 0.3731 |
Price to Book Value | 3.690 |
Earnings Yield | 4.58% |
Market Cap | 500.78M |
PEGY Ratio | 0.3709 |
Operating PE Ratio | 16.19 |
Normalized PE Ratio | 21.81 |